The Olympics have arrived: The challenge of exercise‐induced bronchoconstriction in athletes.

Exercise-induced bronchoconstriction (EIB) is a common condition in athletes, both with and without asthma. It involves the narrowing of the airways during intense exercise and is prevalent among elite athletes. Identifying and monitoring EIB is crucial for determining the best treatment. Inhaled corticosteroids (ICS) can effectively control EIB when taken daily for at least three months. Achieving remission in athletes with severe asthma through targeted treatments that inhibit eosinophils and mast cells is discussed, with the loss of airway hyperresponsiveness to mannitol proposed as a marker for documenting remission. Preventing and managing EIB in athletes, especially during the Olympics, is emphasized, and the use of inhaled corticosteroids is suggested as a potential treatment to reduce the risk of EIB. [Extracted from the article]